#AACRFellows Kevan M. Shokat, PhD, FAACR was presented with the 2026 Stephenson Global Prize for research in pancreatic cancer and delivered his award lecture this afternoon during the AACR Conference on Pancreatic Cancer.
#AACRpan26@sgpcri
We’re proud to announce @kevansf as the recipient of the $1M Stephenson Global Prize for Pancreatic Cancer Research.
His work helped turn “undruggable” KRAS into a target, opening possibilities for people facing pancreatic cancer. And his work is far from finished 🏆
UCSF’s Kevan Shokat, PhD, just won the $1M Stephenson Global Prize for research in pancreatic cancer. He cracked KRAS, a cancer driver long considered “undruggable.” Drugs built on his work now treat lung and pancreatic cancer. https://t.co/5KxIWHMRI6
Our wet-lab validation campaign for Proteina-Complexa is now on bioRxiv! It includes some new exciting experimental results, from large protein structures (fully codesigned!) to functional carbohydrate binders.
https://t.co/r9f0EJMDFJ
Thread with some of the additions 🧵1/n
Looking for an alternative ligand to Cp? Have you tried a phenol?
Check out our newest publication in @J_A_C_S about ruthenium phenoxo complexes in pi-arene activation!
Congrats to @TimSchu34938298 and all involved!
Open access 🔓
https://t.co/q6U13DbED7
We are excited to report a series of covalent inhibitors for K-Ras(G12D) based on a ring-opening alkylation mechanism of malolactones. https://t.co/vjph06kSfj